NASDAQ:EXPO - Exponent Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$52.34 +1.24 (+2.43 %)
(As of 01/16/2019 07:15 AM ET)
Previous Close$51.10
Today's Range$50.73 - $52.50
52-Week Range$34.90 - $54.58
Volume164,875 shs
Average Volume209,268 shs
Market Capitalization$2.66 billion
P/E Ratio48.92
Dividend Yield1.02%
Beta0.53
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
SectorBusiness Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400

Debt

Current Ratio3.82
Quick Ratio3.82

Price-To-Earnings

Sales & Book Value

Annual Sales$347.80 million
Price / Sales7.83
Cash Flow$1.2716 per share
Price / Cash Flow41.16
Book Value$5.60 per share
Price / Book9.35

Profitability

Net Income$41.30 million
Net Margins13.98%
Return on Assets14.34%

Miscellaneous

Employees1,075
Market Cap$2.66 billion
OptionableOptionable

Exponent (NASDAQ:EXPO) Frequently Asked Questions

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Friday, October 19th. Investors of record on Friday, December 7th will be paid a dividend of $0.13 per share on Friday, December 21st. This represents a $0.52 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend is Thursday, December 6th. View Exponent's Dividend History.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were payable to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) issued its quarterly earnings data on Thursday, October, 18th. The business services provider reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.03. The business services provider had revenue of $88.71 million for the quarter, compared to analyst estimates of $88.52 million. Exponent had a return on equity of 20.92% and a net margin of 13.98%. The business's quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.27 EPS. View Exponent's Earnings History.

When is Exponent's next earnings date?

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, January 31st 2019. View Earnings Estimates for Exponent.

What price target have analysts set for EXPO?

3 brokerages have issued 1-year price objectives for Exponent's shares. Their forecasts range from $56.00 to $56.00. On average, they anticipate Exponent's stock price to reach $56.00 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Price Targets for Exponent.

What is the consensus analysts' recommendation for Exponent?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exponent.

What are Wall Street analysts saying about Exponent stock?

Here are some recent quotes from research analysts about Exponent stock:
  • 1. Cantor Fitzgerald analysts commented, ": We continue our bi-weekly Fundamentals and Charts series, in which we look at our coverage universe periodically for an opportunity in names where the Fundamentals match up with the Technicals. We look this week at Overweight-rated EXPO with a 12-month price target of $56. Fundamentally, we believe there is opportunity for upside, as many catalysts exist in a number of areas. We note Exponent has a defensive element to its business. Technically, EXPO trending sideways with the potential to break out to the upside. Click Here for our previous Fundamentals & Charts with EXPO in an uptrend." (1/15/2019)
  • 2. According to Zacks Investment Research, "Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. " (10/22/2018)

Has Exponent been receiving favorable news coverage?

News articles about EXPO stock have been trending very positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Exponent earned a daily sentiment score of 3.9 on InfoTrie's scale. They also assigned news headlines about the business services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days.

Who are some of Exponent's key competitors?

Who are Exponent's key executives?

Exponent's management team includes the folowing people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 64)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 49)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 52)
  • Dr. Harri K. Kytomaa, Group VP of Engineering Sciences & Principal Engineer (Age 59)
  • Dr. Steven J. Murray, Group VP of Mechanics & Materials and Principal Engineer (Age 43)

Who are Exponent's major shareholders?

Exponent's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.52%), Louisiana State Employees Retirement System (0.04%), State of Alaska Department of Revenue (0.03%), Cordasco Financial Network (0.03%) and First Hawaiian Bank (0.00%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss and Sally Shepard. View Institutional Ownership Trends for Exponent.

Which institutional investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Cordasco Financial Network and Louisiana State Employees Retirement System. Company insiders that have sold Exponent company stock in the last year include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Richard L Schlenker Jr and Richard Reiss. View Insider Buying and Selling for Exponent.

Which institutional investors are buying Exponent stock?

EXPO stock was acquired by a variety of institutional investors in the last quarter, including First Hawaiian Bank and State of Alaska Department of Revenue. View Insider Buying and Selling for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $52.34.

How big of a company is Exponent?

Exponent has a market capitalization of $2.66 billion and generates $347.80 million in revenue each year. The business services provider earns $41.30 million in net income (profit) each year or $1.07 on an earnings per share basis. Exponent employs 1,075 workers across the globe.

What is Exponent's official website?

The official website for Exponent is http://www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]


MarketBeat Community Rating for Exponent (NASDAQ EXPO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  192 (Vote Outperform)
Underperform Votes:  189 (Vote Underperform)
Total Votes:  381
MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel